EKO / TSX Venture Exchange
MONTREAL, March 10 /CNW Telbec/ - Management of Noveko International Inc. ("Noveko" or "the Company") wishes to advise its shareholders that to the best of its knowledge, there is no particular reason internal to the Company for the current decline in the share. It is business as usual at Noveko's four subsidiaries. The announced developments are on track and on schedule and management continues to intensify its marketing initiatives in order to achieve the Company's operational and financial objectives between now and the end of the fiscal year as at June 30, 2008.
Profile
-------
Noveko International Inc. currently has four subsidiaries: S.A.S. ECM, Noveko Inc., Laboratoire SyMa Inc. ("SyMa") and Bolduc Leroux Inc. ("BLI"). ECM specializes in the design and marketing of portable real-time ultrasound scanners for use in veterinary and human medicine. Noveko Inc. develops the Company's biomedical and environmental business, specifically its patented antimicrobial filtration technology and derivative products (Noveko(TM) antimicrobial face masks and air filters). SyMa specializes in the manufacture of sanitizers, more specifically the antimicrobial products (for hands, feet and surfaces) sold under the Azuro(TM) trademark. For its part, BLI specializes in the custom processing and distribution of steel products based on client specifications and designs. It has also developed and markets a line of downdraft particle extraction tables for various markets. Operating since September 2002, the Company was listed on the TSX Venture Exchange on February 3, 2004.
The information set forth in this press release includes certain forward-looking statements. Such statements are based on assumptions exposed to major risks and uncertainties. Although Noveko deems the expectations reflected in these forward-looking statements to be reasonable, the Company cannot provide any guarantee as to the materialization of the expectations reflected in these forward-looking statements. The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.